369
Views
8
CrossRef citations to date
0
Altmetric
Epidemiology

Natural history and clinical features of ALS in Malaysia

, , , , , , , , , & show all
Pages 108-116 | Received 17 Aug 2020, Accepted 27 Sep 2020, Published online: 21 Oct 2020

References

  • Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162–72.
  • Marin B, Logroscino G, Boumediene F, Labrunie A, Couratier P, Babron MC, et al. Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol. 2016;31:229–45.
  • Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology 2009;72:1640–5.
  • Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, EURALS, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
  • Rooney JPK, Brayne C, Tobin K, Logroscino G, Glymour MM, Hardiman O. Benefits, pitfalls, and future design of population-based registers in neurodegenerative disease. Neurology 2017;88:2321– 9.
  • Hardiman O, Chalabi AA, Brayne C, Beghi E, van den Berg LH, Chio A, et al. The changing picture of amyotrophic lateral sclerosis: lessons from European registers. J Neurol Neurosurg Psychiatry. 2017;88:557.
  • Tomik B, Nicotra A, Ellis CM, Murphy C, Rabe-Hesketh S, Parton M, et al. Phenotypic differences between African and white patients with motor neuron disease: a case-control study. J Neurol Neurosurg Psychiatry. 2000;69:251–253.
  • Goh KJ, Tian S, Shahrizaila N, Ng CW, Tan CT. Survival and prognostic factors of motor neuron disease in a multi-ethnic Asian population. Amyotroph Lateral Scler. 2011;12:124–129.
  • Malaysia Department of Statistics. Population Quick Info. Available at: http://pqi.stats.gov.my/searchBI.php. Accessed July 22, 2020.
  • Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases World Federation of Neurology Research Group on Motor Neuron D. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–299.
  • de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119:497–503.
  • Pinto WBVR, Debona R, Nunes PP, Assis ACD, Lopes CG, Bortholin T, et al. Atypical Motor Neuron Disease variants: still a diagnostic challenge in Neurology. Rev Neurol (Paris). 2019;175:221–232.
  • Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol. 2014;10:661–670.
  • Atassi N, Berry J, Shui A, Zach N, Sherman A, Sinani E, et al. The PRO-ACT database: Design, initial analyses, and predictive features. Neurology 2014;83:1719–1725.
  • Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481.
  • Rosenbohm A, Liu M, Nagel G, Peter RS, Cui B, Li X, ALS Registry Swabia Study Group, et al. Phenotypic differences of amyotrophic lateral sclerosis (ALS) in China and Germany. J Neurol. 2018;265:774–782.
  • Nalini A, Thennarasu K, Gourie-Devi M, Shenoy S, Kulshreshtha D. Clinical characteristics and survival pattern of 1,153 patients with amyotrophic lateral sclerosis: experience over 30 years from India. J Neurol Sci. 2008;272:60–70.
  • Jun KY, Park JS, Oh KW, Kim EM, Bae JS, Kim I, et al. Epidemiology of ALS in Korea using nationwide big data. J Neurol Neurosurg Psychiatry 2018;0:1–9.
  • Dorst J, Chen L, Rosenbohm A, Dreyhaupt J, Hubers A, Schuster J, Weishaupt JH, et al. Prognostic factors in ALS: a comparison between Germany and China. J Neurol. 2019;266:1516–1525.
  • Xu L, Chen L, Wang S, Feng J, Liu L, Liu G, et al. Incidence and prevalence of amyotrophic lateral sclerosis in urban China: a national population-based study. J Neurol Neurosurg Psychiatry. 2020;91:520– 6.
  • Zhou S, Zhou Y, Qian S, Chang W, Wang L, Fan D. Amyotrophic lateral sclerosis in Beijing: Epidemiologic features and prognosis from 2010 to 2015. Brain Behav. 2018;8:e01131.
  • Watanabe H, Atsuta N, Nakamura R, Hirakawa A, Watanabe H, Ito M, et al. Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:230–236.
  • Doi Y, Atsuta N, Sobue G, Morita M, Nakano I. Prevalence and incidence of amyotrophic lateral sclerosis in Japan. J Epidemiol. 2014;24:494–499.
  • Bae JS, Hong YH, Baek W, Sohn EH, Cho JY, Kim BJ, Korean ALSMND Research Group, et al. Current status of the diagnosis and management of amyotrophic lateral sclerosis in Korea: a multi-center cross-sectional study. J Clin Neurol. 2012;8:293–300.
  • Braga AC, Gromicho M, Pinto S, de Carvalho M, Henning F. A comparative study of South African and Portuguese amyotrophic lateral sclerosis cohorts. J Neurol Sci. 2020;414:116857.
  • Luna J, Diagana M, Aissa LA, Tazir M, Pacha LA, Kacem I, et al. Clinical features and prognosis of amyotrophic lateral sclerosis in Africa: the TROPALS study. J Neurol Neurosurg Psychiatry 2018;0:1–10.
  • Wolf J, Wohrle JC, Palm F, Nix WA, Maschke M, Safer A, et al. Incidence of amyotrophic lateral sclerosis in Rhineland-Palatinate, Germany. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:269–274.
  • Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology 2007;68:1002–1007.
  • Shahrizaila N, Sobue G, Kuwabara S, Kim SH, Birks C, Fan DS, et al. Amyotrophic lateral sclerosis and motor neuron syndromes in Asia. J Neurol Neurosurg Psychiatry. 2016;87:821–830.
  • Mathis S, Goizet C, Soulages A, Vallat JM, Masson GL. Genetics of amyotrophic lateral sclerosis: a review. J Neurol Sci. 2019;399:217–226.
  • Deng X, Hao Y, Xiao B, Tan EK, Lo YL. Prognostic factors of key outcomes for motor neuron disease in a multiracial Asian population. J Clin Neurosci. 2020;72:63–67.
  • Lee CT, Chiu YW, Wang KC, Hwang CS, Lin KH, Lee IT, et al. Riluzole and prognostic factors in amyotrophic lateral sclerosis long-term and short-term survival: a population-based study of 1149 cases in Taiwan. J Epidemiol. 2013;23:35–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.